Ephraim Parent

8PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsRadiation therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2025
PSMA-Directed Theranostics in Prostate Cancer.

Salman Ayub Jajja, Nandini Sodhi, Ephraim E Parent

|Mar 05, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.

Adam M Kase, Justyna Gleba, James L Miller

|Jan 19, 2023
Nuclear Receptor Imaging In Vivo-Clinical and Research Advances.

Ephraim E Parent, Amy M Fowler

|Dec 23, 2022
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT.

Mehmet Asim Bilen, Akinyemi Akintayo, Yuan Liu

|Sep 09, 2022
A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer.

Ephraim E Parent, Adam M Kase

|Mar 25, 2022
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer.

Adam M Kase, Winston Tan, John A Copland

Pageof 2

Frequent Collaborators

3 joint publications

Adam M Kase

2 joint publications

Hancheng Cai

1 joint publications

Omer Kucuk

1 joint publications

Amy M Fowler